Results
|
|
4221.
|
|
|
|
4222.
|
|
|
|
4223.
|
|
|
|
4224.
|
Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study). [electronic resource] by
- Schauwvlieghe, A M E
- Dijkman, G
- Hooymans, J M
- Verbraak, F D
- Hoyng, C B
- Dijkgraaf, M G W
- Van Leeuwen, R
- Vingerling, J R
- Moll, A C
- Schlingemann, Reinier O
Producer: 20160107
In:
BMC ophthalmology vol. 15
Availability: No items available.
|
|
|
4225.
|
Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment: 18-Month, Multicenter, Phase IIIB RELIGHT Study. [electronic resource] by
- Pearce, Ian
- Banerjee, Sanjiv
- Burton, Ben J L
- Chakravarthy, Usha
- Downey, Louise
- Gale, Richard P
- Gibson, Jonathan
- Pagliarini, Sergio
- Patel, Jignesh
- Sivaprasad, Sobha
- Andrews, Chris
- Brittain, Christopher
- Warburton, James
Producer: 20151116
In:
Ophthalmology vol. 122
Availability: No items available.
|
|
|
4226.
|
|
|
|
4227.
|
|
|
|
4228.
|
|
|
|
4229.
|
|
|
|
4230.
|
|
|
|
4231.
|
|
|
|
4232.
|
|
|
|
4233.
|
|
|
|
4234.
|
|
|
|
4235.
|
|
|
|
4236.
|
|
|
|
4237.
|
|
|
|
4238.
|
|
|
|
4239.
|
|
|
|
4240.
|
|